{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:52:46Z","timestamp":1781301166674,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["324084"],"award-info":[{"award-number":["324084"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["3230267"],"award-info":[{"award-number":["3230267"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03472-5","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T13:43:28Z","timestamp":1756043008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Serap","family":"Dede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011fr\u0131","family":"\u015eakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"\u00c7ubukc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muradiye","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayd\u0131n","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayg\u0131n","family":"Alt\u0131ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"3472_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3472_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749\u201368.","journal-title":"JAMA Oncol"},{"key":"3472_CR3","doi-asserted-by":"publisher","first-page":"6548945","DOI":"10.1155\/2022\/6548945","volume":"2022","author":"L Zhao","year":"2022","unstructured":"Zhao L, Liu Y, Zhang S, Li M. Plasma methylated RNF180 for noninvasive diagnosis of gastric cancer. Biomed Res Int. 2022;2022:6548945.","journal-title":"Biomed Res Int."},{"key":"3472_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216399","author":"L Zhao","year":"2022","unstructured":"Zhao L, Li M, Zhang S, Liu Y. Plasma-methylated SEPT9 for the noninvasive diagnosis of gastric cancer. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11216399.","journal-title":"J Clin Med"},{"key":"3472_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3748\/wjg.v29.i4.706","volume":"29","author":"HN Liu","year":"2023","unstructured":"Liu HN, Yao C, Wang XF, Zhang NP, Chen YJ, Pan D, et al. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19\u20139, and carbohydrate antigen 72\u20134 in gastrointestinal cancers. World J Gastroenterol. 2023;29:706\u201330.","journal-title":"World J Gastroenterol"},{"key":"3472_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10238-023-01025-0","volume":"23","author":"H Cao","year":"2023","unstructured":"Cao H, Zhu L, Li L, Wang W, Niu X. Serum CA724 has no diagnostic value for gastrointestinal tumors. Clin Exp Med. 2023;23:2433\u201342.","journal-title":"Clin Exp Med"},{"key":"3472_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144577","author":"V Ebrahimi","year":"2020","unstructured":"Ebrahimi V, Soleimanian A, Ebrahimi T, Azargun R, Yazdani P, Eyvazi S, et al. Epigenetic modifications in gastric cancer: focus on DNA methylation. Gene. 2020. https:\/\/doi.org\/10.1016\/j.gene.2020.144577.","journal-title":"Gene"},{"key":"3472_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s12253-019-00658-5","volume":"26","author":"Z Li","year":"2020","unstructured":"Li Z, Guo Z. Comparison of CDH1 gene hypermethylation status in blood and serum among gastric cancer patients. Pathol Oncol Res. 2020;26:1057\u201362.","journal-title":"Pathol Oncol Res"},{"key":"3472_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.15406\/ghoa.2019.10.00399","volume":"10","author":"E Karamitrousis","year":"2019","unstructured":"Karamitrousis E, Balgkouranidou I, Xenidis N, et al. Methylation status of RASSF1A associates with prognosis in metastatic gastric cancer. Gastroenterol Hepatol Open Access. 2019;10:301\u20134.","journal-title":"Gastroenterol Hepatol Open Access."},{"key":"3472_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.31557\/apjcb.2023.8.1.75-89","volume":"8","author":"A Pathak","year":"2023","unstructured":"Pathak A, Tomar S, Pathak S. Epigenetics and cancer: a comprehensive review. Asia Pac J Cancer Biol. 2023;8:75\u201389.","journal-title":"Asia Pac J Cancer Biol"},{"key":"3472_CR11","first-page":"99","volume":"12","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Fard SS, Reza H, Khorshid K, Yaghmaie M, Mahmoodzadeh H, et al. Methylation analysis of P16, RASSF1A, RPRM, and RUNX3 in circulating cell-free DNA for detection of gastric cancer: a validation study. Avicenna J Med Biotechnol. 2019;12:99.","journal-title":"Avicenna J Med Biotechnol."},{"key":"3472_CR12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062310-094219","author":"C Alix-Panabi\u00e8res","year":"2012","unstructured":"Alix-Panabi\u00e8res C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012. https:\/\/doi.org\/10.1146\/annurev-med-062310-094219.","journal-title":"Annu Rev Med"},{"key":"3472_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02367-x","author":"A Huang","year":"2025","unstructured":"Huang A, Guo DZ, Su ZX, Zhong YS, Liu L, Xiong ZG, et al. Guide: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing. Mol Cancer. 2025. https:\/\/doi.org\/10.1186\/s12943-025-02367-x.","journal-title":"Mol Cancer"},{"key":"3472_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16284","author":"J Qi","year":"2024","unstructured":"Qi J, Hong B, Wang S, Wang J, Fang J, Sun R, et al. Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection. Cancer Sci. 2024. https:\/\/doi.org\/10.1111\/cas.16284.","journal-title":"Cancer Sci"},{"key":"3472_CR15","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.humpath.2009.01.029","volume":"40","author":"XP Zou","year":"2009","unstructured":"Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40:1534\u201342.","journal-title":"Hum Pathol"},{"key":"3472_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203704","author":"T Tsuchiya","year":"2000","unstructured":"Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene. 2000. https:\/\/doi.org\/10.1038\/sj.onc.1203704.","journal-title":"Oncogene"},{"key":"3472_CR17","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1007\/s10620-020-06710-8","volume":"66","author":"H Yan","year":"2021","unstructured":"Yan H, Chen W, Ge K, Mao X, Li X, Liu W, et al. Value of plasma methylated SFRP2 in prognosis of gastric cancer. Dig Dis Sci. 2021;66:3854\u201361.","journal-title":"Dig Dis Sci"},{"key":"3472_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3349\/ymj.2021.62.2.118","volume":"62","author":"SI Seo","year":"2021","unstructured":"Seo SI, Yoon JH, Byun HJ, Lee SK. HOTAIR induces methylation of PCDH10, a tumor suppressor gene, by regulating DNMT1 and sponging with miR-148b in gastric adenocarcinoma. Yonsei Med J. 2021;62:118\u201328.","journal-title":"Yonsei Med J"},{"key":"3472_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21249472","volume":"21","author":"MA Alarc\u00f3n","year":"2020","unstructured":"Alarc\u00f3n MA, Olivares W, C\u00f3rdova-Delgado M, Mu\u00f1oz-Medel M, de Mayo T, Carrasco-Avi\u00f1o G, et al. The reprimo-like gene is an epigenetic-mediated tumor suppressor and a candidate biomarker for the non-invasive detection of gastric cancer. Int J Mol Sci. 2020;21:1\u201315.","journal-title":"Int J Mol Sci"},{"key":"3472_CR20","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/sj.bjc.6602636","volume":"92","author":"WK Leung","year":"2005","unstructured":"Leung WK, To KF, Chu ESH, Chan MWY, Bai AHC, Ng EKW, et al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer. 2005;92:2190\u20134.","journal-title":"Br J Cancer"},{"key":"3472_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cca.2012.01.013","volume":"413","author":"D Yao","year":"2012","unstructured":"Yao D, Shi J, Shi B, Wang N, Liu W, Zhang G, et al. Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. Clin Chim Acta. 2012;413:787\u201394.","journal-title":"Clin Chim Acta"},{"key":"3472_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ijc.10783","volume":"102","author":"KF To","year":"2002","unstructured":"To KF, Leung WK, Lee TL, Yu J, Tong JHM, Chan MWY, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer. 2002;102:623\u20138.","journal-title":"Int J Cancer"},{"key":"3472_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.04.002","volume":"55","author":"CC Wong","year":"2019","unstructured":"Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Semin Cancer Biol. 2019;55:90\u2013105.","journal-title":"Semin Cancer Biol."},{"key":"3472_CR24","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3892\/ol.2014.2410","volume":"8","author":"X Zhang","year":"2014","unstructured":"Zhang X, Zhang X, Sun B, Lu H, Wang D, Yuan X, et al. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer. Oncol Lett. 2014;8:1745\u201350.","journal-title":"Oncol Lett"},{"key":"3472_CR25","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1158\/1078-0432.CCR-07-4522","volume":"14","author":"C Bernal","year":"2008","unstructured":"Bernal C, Aguayo F, Villarroel C, Vargas M, D\u00edaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008;14:6264\u20139.","journal-title":"Clin Cancer Res"},{"key":"3472_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2147\/IJGM.S395951","volume":"16","author":"J Guo","year":"2023","unstructured":"Guo J, Li J, Chang J, Wang L, Xi Y. Value of methylation status of RPRM, SDC2, and TCF4 genes in plasma for gastric adenocarcinoma screening. Int J Gen Med. 2023;16:673\u201381.","journal-title":"Int J Gen Med"},{"key":"3472_CR27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20782","author":"J Wen","year":"2017","unstructured":"Wen J, Zheng T, Hu K, Zhu C, Guo L, Ye G. Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. Oncotarget. 2017. https:\/\/doi.org\/10.18632\/oncotarget.20782.","journal-title":"Oncotarget"},{"key":"3472_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820922559","author":"J Miao","year":"2020","unstructured":"Miao J, Liu Y, Zhao G, Liu X, Ma Y, Li H, et al. Feasibility of plasma-methylated SFRP2 for early detection of gastric cancer. Cancer Control. 2020. https:\/\/doi.org\/10.1177\/1073274820922559.","journal-title":"Cancer Control"},{"key":"3472_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102190","author":"Z Dai","year":"2025","unstructured":"Dai Z, Jiang J, Chen Q, Bai M, Sun Q, Feng Y, et al. Combining methylated RNF180 and SFRP2 plasma biomarkers for noninvasive diagnosis of gastric cancer. Transl Oncol. 2025. https:\/\/doi.org\/10.1016\/j.tranon.2024.102190.","journal-title":"Transl Oncol"},{"key":"3472_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112760","author":"A G\u00f3mez","year":"2021","unstructured":"G\u00f3mez A, Pato ML, Bujanda L, Sala N, Companioni O, Cosme \u00c1, et al. Follow-up study confirms the presence of gastric cancer DNA methylation hallmarks in high-risk precursor lesions. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13112760.","journal-title":"Cancers (Basel)"},{"key":"3472_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mrfmmm.2015.05.002","volume":"778","author":"I Balgkouranidou","year":"2015","unstructured":"Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, et al. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutat Res-Fund Mol Mech Mutagen. 2015;778:46\u201351.","journal-title":"Mutat Res-Fund Mol Mech Mutagen"},{"key":"3472_CR32","first-page":"808","volume":"101","author":"P Guo","year":"2021","unstructured":"Guo P, Zhou X, Xu L, Chen H, Zhao L, Sun M, et al. Application of fecal DNA methylation biomarkers detection in gastric cancer screening. Natl Med J China. 2021;101:808\u201312.","journal-title":"Natl Med J China."},{"key":"3472_CR33","doi-asserted-by":"publisher","first-page":"e2112","DOI":"10.7717\/peerj.2112","volume":"2016","author":"C Pimson","year":"2016","unstructured":"Pimson C, Ekalaksananan T, Pientong C, Promthet S, Putthanachote N, Suwanrungruang K, et al. Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer. PeerJ. 2016;2016:e2112.","journal-title":"PeerJ."},{"key":"3472_CR34","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/cncr.26189","volume":"118","author":"KF Cheung","year":"2012","unstructured":"Cheung KF, Lam CNY, Wu K, Ng EKO, Chong WWS, Cheng ASL, et al. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer. 2012;118:947\u201359.","journal-title":"Cancer"},{"key":"3472_CR35","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.21037\/tcr-20-1330","volume":"9","author":"CQ Cao","year":"2020","unstructured":"Cao CQ, Chang L, Wu Q. Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer. Transl Cancer Res. 2020;9:7012\u201321.","journal-title":"Transl Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03472-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:25:15Z","timestamp":1757420715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03472-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03472-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Biruni University Medical School (2015-KAEK-79\u201323-22). All subjects included in the present study were informed and gave written informed consent. All methods were carried out in accordance with relevant guidelines and regulations. The required consents were taken from the individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The author \u201cEsra Aydemir\u201d declares she is an Editorial Board Member of\u2009<\u2009Discover Oncology\u2009>\u2009and confirms that she was not involved in the handling or decision-making of her own submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing \u0131nterests"}}],"article-number":"1606"}}